Hygeia Pharmaceuticals Inc. news

Hygeia Pharmaceuticals Inc. (VSE: HYG) Hygeia Pharmaceuticals Inc. (VSE: HYG) was awarded a $50,000 Phase I SBIR grant from the National Cancer Institute to develop anti-cancer monoclonal antibodies....